Reverse DCF
What growth does the market imply for AJANTPHARM?
Working backwards from the current price to find the FCF growth assumption baked in.
reasonable
11.5% implied annual FCF growth
The market's growth assumption looks achievable for a quality business. This is within normal range — the stock is not pricing in heroic execution.
Current Price
₹3,131
Historical Growth
-3.1%
FCF Yield
2.23%
Price / FCF
44.9x
Plain English
To justify today's price of ₹3131.00, AJANTPHARM.NS needs to grow its free cash flow at 11.5% per year for the next 10 years. That is 14.6% faster than its historical growth rate of -3.1%. This looks achievable — the market is not pricing in heroic assumptions. There may be genuine upside if the company executes.
Adjust Assumptions
Growth Scenarios
What the stock is worth at different growth assumptions
| Scenario | FCF Growth | Implied IV | MoS vs Price |
|---|---|---|---|
| Historical | -3.1% | ₹918 | -70.7% |
| Half implied | 5.7% | ₹1,922 | -38.6% |
| GDP rate | 10.0% | ₹2,745 | -12.3% |
| Implied | 11.5% | ₹3,131 | +0.0% |
At Historical Growth Rate
DCF horizon: 10 years. At -3.1% growth, the model values AJANTPHARM at ₹918, below today's ₹3,131.
See full DCF analysis
Bear/base/bull scenarios, sensitivity heatmap, reverse DCF, and more.
Run Full Analysis →This is an analytical tool, not investment advice. Implied growth is a mathematical inversion of the DCF model and depends on WACC and terminal growth assumptions. YieldIQ is not registered with SEBI as an investment adviser.